B A C K G R O U N D :
Foreign-born persons in Canada contribute 67% of all tuberculosis (TB) cases annually, but represent only 21% of the total population. Molecular epidemiological studies suggest that most foreign-born TB cases result from the reactivation of latent tuberculous infection (LTBI) acquired before immigration. O B J E C T I V E : To estimate the effect on incidence of a prevention strategy that would screen selected immigrants at arrival for LTBI and offer preventive treatment to those who test positive. D E S I G N : A deterministic model was developed to quantify the incidence of active TB in immigrants to Canada and validated with national immigration and TB case data.
R E S U LT S :
Model simulations suggested that it would be optimal to screen and treat LTBI in new immigrants from countries of birth with an estimated TB incidence rate in excess of 50 per 100 000 person-years. If this strategy had been implemented in 1986, the national TB incidence rate would have fallen by 18.5%, from 5.4 to 4.4 cases per 100 000 population by 2002.
C O N C L U S I O N :
This study suggests that screening and treating LTBI in foreign-born persons from high TB incidence countries is the most effective strategy in terms of total persons screened and treated and percentage reduction in national incidence. K E Y W O R D S : latent tuberculous infection; TB prevention; modelling TB prevention A GROWING PROPORTION of tuberculosis (TB) case patients in low TB incidence immigrant-receiving countries are foreign-born. In Canada, foreign-born persons now account for 67% of reported TB cases, despite comprising only 21% of the total population. 1, 2 There is also a growing disparity in the rate of TB in foreign-born persons in Canada relative to the rate of TB in the Canadian-born non-Aboriginal population: the rate of TB in foreign-born persons was respectively 4 and 19 times greater than the Canadianborn non-Aboriginal population in 1981 and 2011. 2 In molecular epidemiological studies, approximately 85% of the foreign-born TB cases reported in high-income immigrant-receiving countries result from reactivation of latent tuberculous infection (LTBI) acquired abroad before the immigrants' arrival. 3, 4 One cost-effective strategy suggested for use by high-income countries to reduce TB-related morbidity and mortality among foreign-born persons is to fund expanded TB control programmes in high TB incidence countries. [5] [6] [7] Another is the implementation of targeted LTBI screening and treatment strategies within immigrant-receiving countries.
It is generally accepted that reducing TB in foreignborn persons is critically important to TB elimination in immigrant-receiving countries. 5, 8 Nevertheless, targeted screening has not been routinely implemented because of concerns about false-positive tuberculin skin test (TST) results and suboptimal treatment acceptance and adherence rates. 9, 10 These obstacles have been largely overcome with the use of interferongamma release assays (IGRAs) and short-course prophylaxis. 11 Another barrier reasonably relates to uncertainty about the cost-effectiveness of targeted screening. This study seeks to address this uncertainty by identifying a cost-effective screening strategy for LTBI among immigrants newly arrived in Canada using a deterministic mathematical model validated by national TB case and immigration data. Costeffectiveness is described by a ratio that shows the number of persons screened and treated to avert one case of active TB.
METHODS

Deterministic mathematical model
Deterministic mathematical models are models with no random variation among parameter values. A deterministic mathematical model was developed using a system of ordinary differential equations (see Appendix, Methods)* to describe the reactivation of LTBI in foreign-born persons ( Figure 1 ). Foreign-born persons were immigrants or convention refugees who were granted permanent residency and had arrived in Canada between 1986 and 2002. 8 Visitors, students, temporary workers and refugee claimants (those claiming refugee status while in Canada) were excluded due to data limitations. 8 Based on previous findings, 8 strata were included to account for key predictive variables associated with TB incidence in foreign-born populations. Specifically, the population was stratified according to the demographic variables of age at arrival (age ,35 or !35 years as denoted by subscripts 1 and 2, respectively), country of birth group (low, medium or high TB incidence countries) and time since arrival (E, 2 years; M, 3-5 years; and L, .5 years) ( Table 1) . Country of birth groupings used World Health Organization countryspecific estimated rates of smear-positive pulmonary TB, such that low-, medium-and high-incidence countries were those with estimated rates of respectively ,15, 15-50 and .50 cases per 100 000 personyears. 8 The T compartment described the foreign-born population that developed active TB disease. Local transmission of TB with progression to active disease was not considered, as it is a relatively infrequent cause of TB in foreign-born persons. 14, 15 Aging (n E , n M , and n L ), mortality (l), increased time since arrival (e and m) and the continual arrival of new immigrants (b) were considered by the model to account for changes in the foreign-born population over time as well as the transition from one strata to another (Table 1) . Aging was based on the average age of the population (21 years) during the 17-year study period and the length of time people remained in each compartment (E, M and L). Parameters l 1 and l 2 represent mortality rates in the overall Canadian population. 12 The increased time since arrival was estimated using the length of time individuals remain in compartment E and M, which is 2 and 3 years, respectively, therefore e ¼ 1/2 and m ¼ 1/3 year À1 . The continual arrival of new immigrants (b) is timedependent, and was estimated from Citizenship and Immigration Canada (CIC) data. 8 Table 1 outlines the aforementioned model parameters and initial conditions. The intervention parameter b describes the proportion of persons with falsenegative TST results or those who did not adhere to Figure 1 The overall schematic diagram of the LTBI model. The foreign-born population in Canada between 1986 and 2002 was stratified by three incidence groups denoted by i (low ¼ L, ,15; medium ¼ Me, 15-50; and high ¼ H, .50 cases/100 000). The two age groups for the foreign-born population are denoted by subscripts 1 (,35 years) and 2 (!35 years). Compartments E, M, and L describe foreign-born persons who arrived within 2 years, 3-5 years and .5 years, respectively. The T compartment represents the foreign-born population that developed active TB disease. The parameter b describes the average number of people immigrating into Canada per year. The incidence rate per year of active TB from the progression of LTBI from E, M and L compartments is denoted by c, u and w. The parameter denotes the proportion of foreign-born persons who are successfully treated. Transitional parameters describe the annual percentage change due to advancing age (n E , n M and n L ) and time since arrival (e and m). The l rate describes the background mortality. Foreign-born persons who did not undergo screening (1-a) and those who have falsely negative sequential screening tests or did not adhere to preventive treatment (b) have different rates of progression from LTBI to active TB. Those who are falsely negative progress to active TB with a probability rather than an incidence rate (see Appendix, Probability of progression). TB ¼ tuberculosis; LTBI ¼ latent tuberculous infection.
*The Appendix is available in the online version of this article at http://www.ingentaconnect.com/content/iuatld/ ijtld/2014/00000018/00000004/00000007 preventive treatment (see Appendix, The intervention parameter b). Figure 2 describes incidence rates per 100 000 person-years for active TB (c 1 , c 2 , w 1 , w 2 , u 1, and u 2 ). The number of younger (b 1 ) and older (b 2 ) foreign-born persons arriving in Canada per year is given for each country of birth group. Linear and exponential functions were used to find c 1 , c 2 , w 1 , w 2 , u 1 , u 2, b 1 and b 2 that best fit with the immigration data. Data points were excluded as outliers if they were outside 1.5x the interquartile range. Foreign-born persons either screened as falsely negative for LTBI or having incomplete treatment experience a probability of progression to active TB rather than an incidence rate progression. This was achieved by multiplying the incidence rate by (1/p i ) L,Me,H , where p i is the prevalence of LTBI in low-, medium-and high-incidence countries (see Appendix, Probability of progression). Transitional parameters (n E , n M , n L , e, and m) describe the annual percentage change in the size of the foreign-born population between each compartment due to advancing age and time since arrival.
Modelling of prevention strategies
Following development and verification (see Appendix, Model validation), the model was used to estimate the potential impact of various prevention strategies on the reduction of active TB in foreignborn persons. This was achieved by adjusting the parameter b to reflect different prevention strategies being investigated. It also focused on different groups of foreign-born persons as characterised by age at arrival and the TB incidence rate in their country of birth.
All of the prevention strategies were based on the premise that screening for LTBI was initiated at the time of arrival due to the inverse relationship between TB incidence and time since arrival. 8, 16, 17 The approach optimises the early identification of individuals who may have progressed to active TB in the interval between the overseas immigration medical examination and arrival in Canada. 8, [17] [18] [19] In terms of screening, sequential screening tests are more costeffective than using IGRAs alone. 20 The model therefore assumed that foreign-born persons would be screened with a TST and, for those with a positive TST (induration !10 mm), secondarily screened with either the QuantiFERON w -TB Gold In-Tube assay (Cellestis Ltd, Carnegie, VIC, Australia) or the T-SPOT w .TB assay (Oxford Immunotec, Oxford, UK). 11 The parameter (b) related to screening is TST specificity is 59% for HIC (BCG-vaccinated) and 97% for LIC (non-BCG-vaccinated). Assume LIC is 97%, MIC is 78% (middle value), and HIC is 59%. # The initial conditions for compartments M and L are zero since all individuals who arrived in 1986 were in compartment E. **Total TB cases per year were aggregated; accordingly, an equal distribution was assumed in T 1 and T 2 . Note: T 1 and T 2 compartments are not incident cases and are not reported. LIC ¼ low-incidence country; MIC ¼ medium-incidence country; HIC ¼ high-incidence country; LTBI ¼ latent tuberculous infection; TST ¼ tuberculin skin test; IGRA ¼ interferon gamma release assay; TB ¼ tuberculosis; BCG ¼ bacille Calmette-Guérin.
Modelling TB prevention in the foreign-born derived using the pooled sensitivities and specificities of the TST and IGRAs, specifically, a pooled TST sensitivity of 77% and specificity of 59% and 97% in populations that are respectively bacille CalmetteGuérin (BCG) vaccinated and non-BCG-vaccinated. 11, 21 TST specificity was adjusted to account for foreign-born persons who arrived from countries that have a high TB incidence and predictably high rates of BCG vaccination. 22 In this study, the TST specificity was assumed to be 97% for low-and 59% for highincidence countries. A median value of 78% for TST specificity was used for medium-incidence countries. For IGRAs, the model used a pooled sensitivity and specificity of respectively 83% and 97%, as these tests are not influenced by BCG vaccination. 11, 21 Furthermore, it was assumed that TST-positive individuals who were also IGRA-positive would be offered the standard prophylactic treatment regimen of daily isoniazid (INH) for 9 months. 18 As the effectiveness of the treatment for LTBI (INH) is known to be imperfect, treatment failure and adherence rates were considered in evaluating the strategies. Estimates for treatment efficacy assuming perfect adherence was 93%. For imperfect adherence rates of 81% and 65%, the treatment effectiveness was 75% and 60%. 9, 10 In addition, age-related adverse events (mainly hepatotoxicity) due to INH in individuals aged !35 years were included in the model. 23 A prevention strategy that was not restricted by age was also investigated, as emerging preventive therapies are less likely to be associated with agerelated adverse events. 24 The number of people screened and treated per active TB case averted is a ratio (r) used to measure the cost-effectiveness of prevention strategies in this study. A calculation of the health-related costs of screening for LTBI and treating active TB is described in the Appendix. 20 Data sources and materials Microsoft Excel 2007 (Microsoft, Redmond, WA, USA) and Mathematica 7.0 (Wolfram Research, Campaign, IL, USA) were used for data management and model simulation. Ethics approval was not required as the analysis was restricted to nonnominal, routinely collected surveillance data. Based on the study design, only foreign-born persons arriving in 1986 or later could have been beneficiaries of the modelled prevention strategies. The number of TB cases diagnosed between 1986 and 2002 among foreign-born persons who arrived in Canada before 1986 would therefore coincide with the actual number of cases reported in this group and previously described in Langlois-Klassen et al. 8 To estimate the total number of TB cases in the foreignborn population in Canada under any given prevention strategy, TB cases contributed by pre-1986 arrivals were added to the model estimates of TB cases among persons who arrived between 1986 and 2002. National TB incidence rates were estimated using Public Health Agency of Canada (PHAC) surveillance reports and model outcomes (see Appendix, Results).
RESULTS
After cross-validation, the coefficient of determination (R 2 ) for our model was determined to be high (98%), indicating that the model coincided well with the reported data ( Figure 3 , which compares modelderived total TB cases to reported total TB cases). Following the process of cross-validation, various prevention strategies were simulated using the mathematical model. Summarised in Table 2 are nine different strategies (A to I), each at three different levels of effectiveness (60%, 75%, and 93%). For each strategy and each level of effectiveness, the model derived impact on the average annual percentage reduction in national incidence, the incidence rate in 2002 and the effectiveness ratio (r) is given. It can be seen that while strategy B resulted in the highest average annual percentage reduction in national incidence (4.1% at 93% effectiveness) and the lowest incidence rate in 2002 (3.9 cases per 100 000 population), it did so at an r value of 1000.5. Strategy D, on the other hand, while it did not result in as high an average annual percentage reduction in national incidence (3.4% at 93% effectiveness) or as low an incidence rate in 2002 (4.4 cases/100 000), resulted in the lowest r value (681.7). Strategy G, which was the same as strategy D except that it was limited to those aged ,35 years and therefore safer, given that the treatment regimen consisted of daily INH for 9 months, resulted in a comparable r value (683.8), but a lower average annual percentage reduction in national incidence (3.0% at 93% effectiveness), and a higher incidence rate in 2002 (4.7 cases/100 000). Depicted graphically in Figure 4 are the modelderived annual incidence rates between 1986 and 2002 using strategy B (upper panel) and strategy D (lower panel). Using data obtained from TB surveillance reports published by PHAC (see Appendix Results), the national incidence can be seen to compare favourably with model simulations (R 2 ¼ 91%).
DISCUSSION
The treatment of LTBI has the potential to reduce the incidence of active TB. 25 Its cost-effectiveness has been studied in Canada. 20, 26, 27 Based on the strategies modelled here, the targeted screening and treatment of LTBI among foreign-born persons (all ages or those aged ,35 years) from high-incidence countries on arrival is the optimal prevention strategy (Strategy D or Strategy G), based on their low effectiveness ratios. Other studies looking at the effectiveness of prevention strategies support the idea of focusing on foreign-born persons at higher risk of developing TB. 5, 20, 26 The optimal strategy based on our model also includes considerations of adverse events from INH treatment for people aged ! 35 years. 23 In anticipation of emerging therapies that are likely to be safer in older age groups, the optimal strategy (Strategy D) would achieve lower incidence rates in 2002 compared with Strategy G. Newer and shorter LTBI treatment regimens, such as 4 months of daily rifampicin 28 or 12 weeks of once-weekly INHþrifapentine, 24, 29 suggest that the age-dependent TB prevention strategies and lower adherence estimates modelled in this study are quite conservative.
A post-hoc analysis was conducted to compare the effectiveness of a strategy that used the proposed screening method, TSTþIGRA, with a strategy that used IGRA alone as the screening method (see Appendix Discussion). This analysis was limited to Strategy D. At 75% effectiveness, the incidence rate at the end of the study period (year 2002) would have been lower for the IGRA only (4.4 cases/100 000) than the TSTþIGRA strategy (4.6 cases/100 000). The annual average reduction in incidence was increased by 0.3% in the IGRA-only approach, but required an additional investment of 3-4 million dollars per year. Although the proposed strategy (TSTþIGRA) describes the most cost-effective approach, 20 the IGRA-only approach is not without benefit. The benefits include ease of test performance, greater specificity in populations with high rates of BCG vaccination and non-tuberculous mycobacteria, and limiting follow-up to those with positive test results. 30 With respect to Canada's Stop TB goal of achieving an incidence rate (in lieu of prevalence) of 3.6 cases/ 100 000 by 2015, 31,32 model predictions suggest that, if Strategy D was used, a national incidence rate of 4.6 cases/100 000 (ef ¼ 75%) would have been achieved in 2002. Reaching Stop TB goals in Canada requires not only the prevention of disease in the foreign-born, but also the interruption of transmission and prevention of disease in Canada's indigenous peoples. 2 This study has certain limitations. First, the model did not directly account for the likely failure of standard treatment among foreign-born persons infected with INH-resistant strains. The effectiveness rate of 93% indirectly accounted for INH resistance given that the estimated prevalence of the latter is between 7% and 10% in the foreign-born population Figure 4 National TB incidence rates for screening and treating 100% of all foreign-born people from HIC and MIC (top) and 100% of foreign-born people from HIC only (bottom) at 93%, 75% and 60% effectiveness. TB ¼ tuberculosis; MIC ¼ medium-incidence country; HIC ¼ high-incidence country.
of Canada. 17 In a post-hoc analysis that assumed an INH resistance rate of 7.9% in foreign-born persons with LTBI and an effectiveness rate of 85% (see Appendix, Discussion), there was little change in the average annual percentage reduction in national incidence. Newer and shorter LTBI treatment regimens would improve overall treatment effectiveness for this prevention strategy. Second, the foreign-born population in this study did not include refugee claimants whose incidence rates are not known for certain, although these are generally thought to be higher than landed immigrants. Finally, the effectiveness ratio, which described the number of foreignborn persons needing to be screened and treated to avert one case of active TB, did not include a detailed accounting of costs such as those related to drug resistance, treatment complications, administration and program implementation. 20, 33 Its estimate was understood to be a relative measure that provides meaningful insight into strategies that require a closer examination.
CONCLUSION
Reducing TB among the foreign-born will ultimately have a positive impact on the health of immigrants, national TB rates and national TB elimination targets in Canada and other high-income immigrant-receiving countries. Using a deterministic mathematical model validated by national TB data, this study suggests that a strategy of screening and treating LTBI in foreign-born persons (all ages or those aged ,35 years) from high-incidence countries at arrival would be optimal. Integrating epidemiological data in a mathematical model provides valuable insight into issues of public health importance.
APPENDIX METHODS
The ordinary differential equation system of the latent tuberculous infection model
Here, 'i' represents a model stratified by country of birth group: low-(LIC), medium-(MIC) and highincidence countries (HIC). The ordinary differential equation (ODE) system above represents foreignborn individuals who did not undergo screening. A similar ODE system representing foreign-born individuals who had false-negative sequential screening tests or did not complete preventive treatment was evaluated simultaneously. This system is presented below:
i¼L;Me;H Modelling TB prevention in the foreign-born i
The intervention parameter b The parameter b is described by: 
Model validation
The mathematical model was validated using national TB case and immigration data between 1986 and 2002. The TB case data obtained from the Canadian Tuberculosis Reporting System (CTBRS) and the immigrant data provided by Citizenship and Immigration Canada (CIC) was previously described by Langlois-Klassen et al. 1 Data from the CTBRS consisted of all foreign-born active TB cases diagnosed during the study period (isoniazid resistance in foreign-born new active cases was 7.9% between 2006 and 2010). 1 Cross-validation (holdout method) was used to overcome the challenge of validating dependent data. As model parameters and initial conditions were estimated using the CTBRS and CIC data, the hold-out method used half the data set for model simulations and independently compared results with the other half.
The primary outcome for cross-validation was total active TB cases per year. The coefficient of determination (R 2 ) was estimated to measure the strength of the validation, with high values indicating a better fit of the primary outcome during the study period
Estimation of national tuberculosis incidence National TB case counts were calculated through the integration of model outcomes for TB cases among 1986-2002 arrivals with that of pre-1986 arrivals (see Data Sources and Materials) and Canadian-born population groups. TB incidence data for Canadianborn persons were obtained from Public Health Agency of Canada (PHAC) surveillance reports. [2] [3] [4] The case counts, excluding those contributed by the foreign-born population group, were estimated using PHAC surveillance reports. Case counts contributed by the foreign-born population group were estimated by adding the 1986-2002 arrivals using model simulations and the pre-1986 arrivals. National incidence rates were obtained by dividing the new total TB cases (PHAC surveillance reports, model simulations and estimates previously described by Langlois-Klassen et al.) by the total population obtained from surveillance reports (Table A.1) . 1 
RESULTS
Calculation of national TB rate: surveillance report information TB surveillance report data for 1986 to 2002 were used to estimate national TB incidence in Canada (Table A. 1) . The population at risk is estimated by dividing the total new and relapsed TB cases (column 2) by the reported TB incidence rate (column 3). The new national TB rate was estimated by combining all TB cases totals (column 5) with model outcomes divided by the population at risk for each calendar year.
ii (Table A. 2). Treatment effectiveness using the LTBI model and assuming an isoniazid resistance rate of 7.9% in foreign-born persons in Canada. Optimal strategies are used to evaluate the overall impact on the national incidence rate in 2002 (Table A. 3). Les simulations réalisées grâceà ce modèle ont suggéré que la meilleure stratégie serait de dépister et de traiter la LTBI chez les immigrants nés dans des pays où l'incidence de la TB est estiméeà .50/ 100 000 personnes-années. Si cette stratégie avaitété mise en oeuvre en 1986, en 2002 l'incidence nationale de la TB serait tombée de 5,4à 4,4 cas/100 000 habitants, soit une diminution de 18,5%. C O N C L U S I O N : Cetteétude suggère que dépister et traiter la LTBI chez des personnes nées dans des paysà forte incidence de TB est la stratégie la plus efficace en termes de nombre total de personnes dépistées et traitées et de réduction de l'incidence nationale de la TB.
R E S U M E N M A R C O D E R E F E R E N C I A :
Las personas que residen en el Canadá nacidas en el extranjero representan el 67% de todos los casos de tuberculosis (TB) cada año, pero constituyen solo el 21% del total de la población. Los estudios de epidemiología molecular indican que la mayoría de los casos de TB en las personas nacidas en el extranjero proviene de la reactivación de una infección tuberculosa latente (LTBI) adquirida antes de la inmigración. O B J E T I V O : Calcular la repercusión en la incidencia de TB de una estrategia de prevención que consista en detectar sistemáticamente la LTBI en algunos inmigrantes y ofrecer el tratamiento preventivo a los que presentan un resultado positivo.
M É T O D O :
Se aplicó un modelo determinista con el fin de cuantificar la incidencia de TB activa en los inmigrantes al Canadá y se validó el modelo con los datos del servicio nacional de inmigración y del registro de casos de TB. R E S U LTA D O S : Los modelos de simulación indicaron que seríaóptimo practicar la detección sistemá tica y tratar la LTBI en los nuevos inmigrantes que nacieron en países que presentan una tasa de incidencia calculada por encima de 50/100 000 años-persona. Si esta estrategia se hubiese introducido en 1986, la tasa de incidencia nacional de TB en el 2002 habría sido un 18,5% más baja, con 5,4-4,4 casos/100 000 habitantes. C O N C L U S I Ó N : Los resultados del presente estudio indican que la detección sistemá tica y el tratamiento de la LTBI en las personas nacidas en países con una alta incidencia de TB es la estrategia má s eficaz con respecto al número de personas examinadas y tratadas y al porcentaje de disminución de la incidencia nacional de la TB.
